These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35327653)

  • 41. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
    Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
    Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Nrf2 contribute to p53-mediated control of cell survival and death?
    Chen W; Jiang T; Wang H; Tao S; Lau A; Fang D; Zhang DD
    Antioxid Redox Signal; 2012 Dec; 17(12):1670-5. PubMed ID: 22559194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
    Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
    Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Landscape of Nrf2 and p53 Pathway Activation Dynamics by Oxidative Stress and DNA Damage.
    Hiemstra S; Niemeijer M; Koedoot E; Wink S; Klip JE; Vlasveld M; de Zeeuw E; van Os B; White A; Water BV
    Chem Res Toxicol; 2017 Apr; 30(4):923-933. PubMed ID: 27982581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.
    Wu S; Zhang T; Du J
    Drug Des Devel Ther; 2016; 10():3471-3481. PubMed ID: 27822011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells.
    Jang CH; Moon N; Oh J; Kim JS
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
    Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway.
    Chian S; Zhao Y; Xu M; Yu X; Ke X; Gao R; Yin L
    Anticancer Drugs; 2019 Sep; 30(8):838-845. PubMed ID: 31415285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
    Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
    Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
    Fraser M; Bai T; Tsang BK
    Int J Cancer; 2008 Feb; 122(3):534-46. PubMed ID: 17918180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling.
    Chen L; Yang R; Qiao W; Zhang W; Chen J; Mao L; Goltzman D; Miao D
    Aging Cell; 2019 Jun; 18(3):e12951. PubMed ID: 30907059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
    Wu X; Lu Y; Qin X
    J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
    Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
    Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
    BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulforaphane decreases endothelial cell apoptosis in fuchs endothelial corneal dystrophy: a novel treatment.
    Ziaei A; Schmedt T; Chen Y; Jurkunas UV
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6724-34. PubMed ID: 24030461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.
    Bagnoli M; Balladore E; Luison E; Alberti P; Raspagliesi F; Marcomini B; Canevari S; Mezzanzanica D
    Mol Cancer Ther; 2007 Feb; 6(2):762-72. PubMed ID: 17308072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
    Wang XJ; Li Y; Luo L; Wang H; Chi Z; Xin A; Li X; Wu J; Tang X
    Free Radic Biol Med; 2014 May; 70():68-77. PubMed ID: 24556415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulforaphane protects against cisplatin-induced nephrotoxicity.
    Guerrero-Beltrán CE; Calderón-Oliver M; Tapia E; Medina-Campos ON; Sánchez-González DJ; Martínez-Martínez CM; Ortiz-Vega KM; Franco M; Pedraza-Chaverri J
    Toxicol Lett; 2010 Feb; 192(3):278-85. PubMed ID: 19913604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.